| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $330.53M | $108.46M | $48.66M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $555.34M | $501.88M | $527.23M | $449.21M | $344.41M |
| R&D | $418.78M | $396.44M | $423.88M | $358.73M | $265.35M |
| SG&A | $136.56M | $105.44M | $103.35M | $90.47M | $79.06M |
| Operating Income | -$555.34M | -$487.34M | -$196.70M | -$340.74M | -$295.75M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $102.00K | $68.00K | $30.00K | $21.00K | -$575.00K |
| Net Income | -$512.54M | -$422.77M | -$145.22M | -$325.99M | -$290.58M |
| EPS (basic) | -2.9700 | -2.5700 | -1.0600 | -2.6000 | -2.3900 |
| EPS (diluted) | -2.9700 | -2.5700 | -1.0600 | -2.6000 | -2.3900 |
| Shares (diluted) | $172.65M | $164.47M | $137.37M | $125.53M | $121.52M |